methazolamide has been researched along with Spondylitis, Ankylosing in 2 studies
Methazolamide: A carbonic anhydrase inhibitor that is used as a diuretic and in the treatment of glaucoma.
Spondylitis, Ankylosing: A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.
Excerpt | Relevance | Reference |
---|---|---|
"Methazolamide is a carbonic anhydrase (CA) inhibitor with satisfactory safety." | 1.91 | Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA. ( Gao, P; Liang, W; Liu, Q; Sun, T; Wang, M; Yan, X, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Sun, T | 1 |
Wang, M | 1 |
Liang, W | 1 |
Gao, P | 1 |
Liu, Q | 1 |
Yan, X | 2 |
Chang, X | 1 |
Zhang, Y | 1 |
2 other studies available for methazolamide and Spondylitis, Ankylosing
Article | Year |
---|---|
Revealing mechanism of Methazolamide for treatment of ankylosing spondylitis based on network pharmacology and GSEA.
Topics: Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Molecular Docking Simulation; Network Pharmaco | 2023 |
Treat ankylosing spondylitis with methazolamide.
Topics: Administration, Oral; Carbonic Anhydrase Inhibitors; Humans; Methazolamide; Spondylitis, Ankylosing | 2011 |